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ABSTRAK 
 
 
 
 
HUBUNGAN ANTARA KERUNSINGAN DAN GEJALA AFEKTIF DALAM 
PENGHIDAP KECELARUAN BIPOLAR YANG MENGHADIRI RAWATAN 
ULANGAN 
 
Latar Belakang: Gejala kerunsingan kerap berlaku pada pesakit Kecelaruan Bipolar. Ia 
dikaitkan dengan keadaan penyakit yang lebih serius, contohnya penyakit yang lebih 
kerap berulang, kemasukan ke hospital yang lebih kerap, penyalahgunaan dadah, serta 
simptom kemurungan dan mania yang lebih teruk. Setakat ini, kajian mengenai 
kerunsingan pada pesakit Bipolar di Malaysia masih berkurangan.  
 
Tujuan kajian: Kajian ini bertujuan untuk menentukan kelaziman simptom 
kerunsingan dan pengesanannya pada pesakit rawatan ulangan yang menghidapi 
Kecelaruan Bipolar. Data sosiodemografi dan klinikal yang berkaitan dengan simptom 
keresahan dikenalpasti. Korelasi antara keresahan dan gejala afektif serta bebanan 
peristiwa hidup dalam setahun juga dikaji.  
 
Kaedah kajian: Kajian keratan rentas ini dijalankan ke atas pesakit Kecelaruan Bipolar 
di Klinik Psikiatri Hospital Universiti Sains Malaysia. Peserta kajian memberikan 
maklumat sosiodemografi dan klinikal serta mengisi empat skala penilaian sendiri 
[Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), Young Mania 
Rating Scale (YMRS) dan Social Readjustment Rating Scale (SRRS)] untuk 
mengenalpasti tahap kemurungan, mania dan keresahan, serta tahap peristiwa hidup 
dalam setahun. Analisis regresi dan korelasi dilakukan untuk mengenalpasti kaitan dan 
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korelasi antara simptoms keresahan dan simptom afektif serta data sosiodemografi dan 
klinikal. 
 
Keputusan: 20.5% daripada kesemua 132 orang peserta kajian mempunyai gejala 
kerunsingan yang signifikan. Daripada peratusan tersebut, hanya 29.3% peserta telah 
dikenalpasti oleh pegawai perubatan yang merawat sebagai mengalami gejala 
kerunsingan. Tahap kerunsingan (BAI) mempunyai kaitan secara langsung yang positif 
dengan Kecelaruan Bipolar jenis II, jumlah penyakit berulang serta skala BDI. Terdapat 
korelasi positif yang baik antara BAI dan BDI (r = 0.690, p < 0.001), manakala terdapat 
korelasi positif yang lemah antara BAI dan SRRS (r = 0.194, p = 0.026). 
 
Kesimpulan: Pengenalpastian gejala kerunsingan pada pesakit Bipolar oleh pegawai 
perubatan yang merawat adalah rendah. Kerunsingan dalam pesakit Bipolar adalah 
berkaitan dengan Kecelaruan Bipolar jenis II, jumlah penyakit yang lebih kerap 
berulang, simptom kemurungan yang lebih teruk serta bebanan peristiwa hidup yang 
lebih banyak dalam masa setahun. Pegawai perubatan yang merawat perlu sensitif 
dalam mengesan kerunsingan dalam pesakit Kecelaruan Bipolar. Lebih banyak kajian 
diperlukan untuk mencari rawatan yang berkesan untuk keresahan dalam pesakit 
Kecelaruan Bipolar. 
 
Kata kunci: Kecelaruan Bipolar, kemurungan, keresahan, pengesanan, peristiwa 
kehidupan 
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ABSTRACT 
 
 
 
 
THE ASSOCIATION OF ANXIETY AND MOOD SYMPTOMS IN PATIENTS 
WITH BIPOLAR DISORDERS ATTENDING FOLLOW-UP TREATMENT 
 
Background: Anxiety is common in Bipolar Disorders (BD). It is associated with 
poorer outcome in BD, for example increased in relapse rate and hospitalization, 
suicidality, substance abuse and more severe symptoms of mania and depression. 
Malaysian study regarding anxiety in BD is still lacking.  
 
Objective: The aim of this study was to determine prevalence of significant anxiety and 
its detection rate in psychiatric outpatient clinic. Sociodemographic and clinical 
characteristics associated with anxiety were also examined. Correlation between anxiety 
and mood symptoms and the burden of life events within one-year period were 
measured.  
 
Method: This is a cross-sectional study done in psychiatric outpatient clinic in Hospital 
Universiti Sains Malaysia. Sociodemographic and clinical data were acquired from 
selected samples and four self-rated scales [Beck Anxiety Inventory (BAI), Beck 
Depression Inventory (BDI), Young Mania Rating Scale (YMRS) and Social 
Readjustment Rating Scale (SRRS)] were administered to measure mood symptoms, 
anxiety symptoms and the burden of life events within the previous one year. 
Regression and correlation analysis were done to examine relationship between anxiety 
symptoms and mood symptoms and sociodemographic and clinical data.  
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Results: 20.5% of the total 132 participants had significant level of anxiety. Among 
these, only 29.3% were detected by clinicians. Anxiety level (BAI) in BD was 
positively and independently associated with Bipolar II Disorder, number of relapse and 
BDI score. There was strong positive correlation between BAI and BDI (r = 0.690, p < 
0.001). There was weak positive correlation between BAI and SRRS (r = 0.194, p = 
0.026). 
 
Conclusion: Anxiety in BD is poorly detected by clinicians and was associated with 
Bipolar II Disorder, higher frequency of relapse, more severe depression, and more 
burdens of life event within one-year period. Clinicians need to be sensitive in detecting 
anxiety in BD. More research is needed in finding effective treatment for anxiety in BD. 
 
Keywords: anxiety, Bipolar Disorders, depression, detection, life events 
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CHAPTER 1:  INTRODUCTION 
 
 
 
 
Mental illness affects around 450 million of the world population (World Health 
Organization 2003). In Malaysia, it is estimated that 1.1 million adults are affected with 
mental illness (Malaysia Ministry of Health 2011). Mental illness causes major 
disabilities to the affected and causes distress and suffering to the sufferer and family 
members.  
 
Bipolar Disorders are one of the major psychiatric disorders along with schizophrenia 
and Major Depressive Disorder. Its main feature is fluctuations of mood ranging from 
depression to mania or hypomania. The main aim of treatment of Bipolar Disorder is to 
stabilize the mood so that the person with the disease is free from extreme fluctuations 
of mood, leading to a state of euthymia. However clinicians frequently fail to address 
other important symptom of the illness, namely anxiety. 
 
Studies show that anxiety comorbidity in Bipolar Disorder is very common. Lifetime 
prevalence of Anxiety Disorder was found to be up to 60% (Zutshi et al. 2006). Anxiety 
is associated with poorer course of illness in Bipolar Disorders such as increased in 
relapse and hospitalization, and increased in drug abuse and suicidality (Márcia Kauer-
Sant’Anna et al. 2007). It is also associated with poorer quality of life (Simon et al. 
2004).   
 
! 2!
Treatment of Bipolar Disorders with the presence anxiety is complicated. Usual 
medications to treat Bipolar Disorders might not be as affective as in Bipolar Disorders 
without anxiety (Gaudiano & Miller 2005).  Usual medications to treat anxiety if used 
in the context of comorbidity with Bipolar Disorders might cause destabilization of 
mood (Ghaemi & Hsu 2003).  
 
A lot of research is still needed to examine nature and treatment of anxiety in Bipolar 
Disorders.  
 
 
 
 
 
 
 
 
 
 
 W!!!!!!!!!! !
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CHAPTER 2:  LITERATURE REVIEW 
 
 
 
Mental illness is common. Its lifetime prevalence is more than 25% in developed and 
developing countries. Aggregate point prevalence for neuropsychiatric disorders is 
10%, and it is estimated that 450 million people are affected by these disorders (World 
Health Organization 2003).  
 
Mental disorders cause major disabilities to their sufferers. World Health Organization 
(WHO) estimated disability-adjusted life year (DALY) lost due to mental illness in 
1990 to be 10.5%. The figure increased to 12.3% in the year 2000. It is estimated that 
DALYs for mental illness to increase to 15% in 2020 (WHO 2003).  
 
Bipolar Disorders are the 9th contributor to the leading cause of DALYs in both sexes 
aged 14 – 44 years old.  With total DALYs of 2.5%, it is only behind unipolar 
depression, alcohol use disorders, self inflicted injuries and Schizophrenia (WHO 
2003).  
 
In Malaysia, more than five percent of those 16 years and above have current mental 
illness (Malaysia Ministry of Health 2011; Krishnaswamy et al. 2012). It is estimated 
that 1.1 million Malaysian adults suffer from psychiatric illness (Malaysia Ministry of 
Health 2011).  
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2.1 Mood Disorder and Bipolar Disorders 
 
Mood Disorder is a group of psychiatric disorders in which the clinical pictures show 
pathological moods and their related psychomotor features (Sadock et al. 2009). Major 
Mood Disorders include Bipolar Disorders and Major Depressive Disorder.  
 
Bipolar Disorders are divided mainly into Bipolar I Disorder and Bipolar II Disorder, in 
which Bipolar I Disorder is the more severe form. To diagnose Bipolar I Disorder, a 
person needs to have at least one episode of mania with or without history of 
depression. As for Bipolar II Disorder, the person have at least one episode of 
hypomania and one episode of Major Depressive Disorder (American Psychiatric 
Association 2013).  
 
Mania is characterized by elevated mood with talkativeness, increased activities and 
energy, reduced need for sleep, irritability, heightened sensorium, increased in libido 
and impulsivity. It could progress to psychosis, which is characterized by paranoid and 
grandiose delusion and hallucination (Gelder et al. 2003). Hypomania is the milder form 
of mania in which there is no psychosis and more or less no functional impairment. 
 
Depression is a state in which the mood is low, bleak and pessimistic and the person is 
unable to experience pleasure. Thoughts as well as physical movement become slow. 
Neurovegetative activities such as sleep, appetite and libido also decreased. Psychosis 
may also occur in severe depression (Gelder et al. 2003). 
 
The mainstay treatments for Bipolar Disorders are mood stabilizers and antipsychotics.  
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Since its discovery in 1960s, lithium has been widely used as a mood stabilizer. It has 
the most data on effectiveness for manic and depressive phase of illness (Malhi et al. 
2013). It also fulfills all the proposed definition of mood stabilizer due to its 
effectiveness in acute manic and depressive state, as well as a prophylaxis against 
recurrence of mania and bipolar depression. Hence, it is still considered the ‘gold 
standard’ mood stabilizer (Ghaemi 2003).  
 
Other mood stabilizers recommended for Bipolar Disorders include sodium valproate, 
lamotrigine and carbamazepine. Recommended antipsychotics include olanzapine, 
quetiapine, aripiprazole and typical antipsychotics such as haloperidol (Yatham et al. 
2013). 
 
Psychotherapy such as cognitive behavioral therapy and interpersonal and social rhythm 
therapy are also suitable for some patients, particularly in Bipolar II Disorder (Yatham 
et al. 2013).  
 
2.2 Anxiety  
 
Abnormal anxiety in an unpleasant emotional sensation due to ‘fear for no adequate 
reason’ (Casey & Kelly 2007). The individual frequently has physical symptoms such 
as palpitation, restlessness, shortness of breath and increased sweating. Cognitive 
symptoms of anxiety include worries or having a sense of something bad but unknown 
is going to happen.  Anxiety could be mild to moderate and free-floating to severe, 
presenting with fear and panic. 
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There are various illnesses in which anxiety is the main features. This include 
Generalized Anxiety Disorder and Panic Disorder (American Psychiatric Association 
2013).  
 
Generalized Anxiety Disorder is a condition in which there is persistent worries 
occurring almost every day which is associated with symptoms such as fatigue, 
problems with concentration and irritability. 
 
Panic Disorder is a condition in which there are panic attacks associated with persistent 
worry about getting another attacks and change in behaviors associated with the worry.  
Panic attacks are sudden unexpected extreme anxiety that are accompanied by 
palpitations, sweating, trembling, nausea and other symptoms. 
 
Recommended first line treatment for anxiety disorders are Selective Serotonin 
Reuptake Inhibitors (SSRI) such as escitalopram and sertraline; and Serotonin and 
Norepinephrine Reuptake Inhibitors (SNRI) such as venlafaxine and duloxetine 
(Bandelow et al. 2012). 
 
2.3 Anxiety and Bipolar Disorders 
 
Bipolar Disorders are highly comorbid with other mental illness. Comorbidities of 
Bipolar Disorders include substance abuse and various anxiety disorders (Merikangas & 
Jin 2011). 
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It is widely thought that between the intervals of depression and mania or hypomania, 
patients with Bipolar Disorders return to the normal state of wellbeing with mood being 
euthymic and functioning returning to normal. However, the fact that a number of 
bipolar patients still have ongoing symptoms between the affective episodes is 
increasingly recognized. For example, Macqueen et al. (2003) followed 138 patients for 
3 years and found that around 26% of them had subsyndromal symptoms between the 
episodes, and had some difficulties in functioning with Global Assessment of 
Functioning scores averaging 69. This means that around one-third of these patients are 
at least mildly symptomatic and experiences some difficulties in functioning in daily 
life.  
 
The affective phenomenon of mania, hypomania and depression are regarded as the 
main conditions that characterize the Bipolar Disorders that the other important facets 
of it, the anxiety symptoms, are often overlooked.  
 
In the 19th century, Kraepelin (1921)  already recognized the symptoms of anxiety in 
Bipolar Disorders, formerly known as Manic Depressive Insanity. He described 
“depressive or anxious mania” as “morbid state arises, which is composed of flight of 
ideas, excitement and anxiety … mood is anxiously despairing, it gives itself vent in 
great restlessness”. In the phase of “excited depression”, he stated that “mood is 
anxious, despondent, lachrymose, irritable…”  
 
Research found that current Anxiety Disorder comorbidity in Bipolar Disorders to be 
ranging from 19 to 56 percent (Márcia Kauer-Sant’Anna et al., 2007; Mantere et al., 
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2010; Simon et al., 2004). Lifetime comorbidity of Anxiety and Bipolar Disorders is 
slightly higher, ranging from 51 to 61 percent (Simon et al. 2004; Zutshi et al. 2006). 
 
Data from Singapore showed that Generalized Anxiety Disorder comorbidity of Bipolar 
Disorders was 18.1% (Subramaniam et al. 2013). Other anxiety disorders are not stated. 
So far, there is no data on Anxiety Disorder comorbidity in Malaysian setting. 
 
Anxiety Disorder brings a challenge in managing Bipolar Disorders as it alters the 
course, functioning and treatment of Bipolar Disorders patients. 
 
The onset of Bipolar Disorders is significantly earlier in the presence of Anxiety 
Disorder comorbidity. Systematic Treatment Enhancement Program for Bipolar 
Disorder (STEP-BD) participants with comorbid Anxiety Disorder had significantly 
lower mean age of onset of Bipolar Disorders, which is 15 years old, as compared to 19 
years old in Bipolar Disorders without comorbidity (Simon et al. 2004). Other study 
also showed significant age difference, which is 19 years old in Bipolar Disorders 
comorbid with Anxiety Disorder, and 23 years old in patients without an Anxiety 
Disorder (Zutshi et al. 2006). 
 
The presence of Anxiety Disorder is associated with higher level of depressive and 
manic symptoms (Gaudiano & Miller 2005), rapid cycling, and psychosis (Márcia 
Kauer-Sant’Anna et al. 2007) as compared to Bipolar Disorders without anxiety 
comorbidity. Anxiety symptom level is also found to be positively correlated with the 
level of depression (Mantere et al., 2010). With treatment, anxiety level reduced along 
with the level of depression.   
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Patients with comorbid Mood Disorders and Anxiety Disorders also show high degree 
of impulsivity. However Anxiety Disorder-Bipolar Disorders comorbidity shows higher 
impulsivity than Anxiety Disorder-Major Depressive Disorder comorbidity (Bellani et 
al. 2012). 
 
There is a higher risk of alcohol and drug abuse (Márcia Kauer-Sant’Anna et al. 2007) 
in Bipolar Disorders patients who have Anxiety Disorder. It is also associated with 
more suicide attempts (Márcia Kauer-Sant’Anna et al. 2007; Simon et al. 2004). 
 
The presence of anxiety in bipolar patients showed poorer quality of life, more 
impairment in functioning, and lower General Assessment of Functioning (GAF) score. 
These patients also experiences significantly less time being in euthymia, and increased 
severity and chronicity of illness (Márcia Kauer-Sant’Anna et al. 2007; Simon et al. 
2004; Gaudiano & Miller 2005). 
 
Treatment for comorbidity of anxiety in Bipolar Disorders is not as straight forward as 
treating these disorders separately. Antidepressants, which are the medication of choice 
for Anxiety Disorders, may destabilize the mood and cause manic switch and rapid-
cycling Bipolar Disorders (Ghaemi & Hsu 2003).  Treatment for Anxiety Disorders in 
the setting of Bipolar Disorders that is recommended by Canadian Network for Mood 
and Anxiety Treatments (CANMAT) include first line treatment with gabapentin and 
quetiapine, and also sodium valproate, lamotrigine and SSRI as the second line 
treatment (Schaffer et al. 2012).  
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Bipolar Disorders with comorbid anxiety also showed poorer response to both treatment 
of pharmacotherapy and psychotherapy (Gaudiano & Miller 2005). It responds less to 
mood stabilizing agents which were lithium and anticonvulsants (Boylan et al. 2004; 
Henry et al. 2003), and showed less antimanic response of olanzapine (Joshi et al. 2010; 
Henry et al. 2003). 
 
Overall, the presence of Anxiety Disorder comorbidity indicates poorer prognosis of 
this already chronic and debilitating illness. 
 
2.4 Life Events  
 
Effects of life events on medical illness have been observed in research. Rahe et al. 
(1964) found that a number of life events requiring certain adjustment within two-year 
period are associated with the onset of tuberculosis, heart disease, inguinal hernia and 
skin diseases. 
 
This is also true for psychiatric illness. A community survey was done to observe 
relationship between life events over the past 12 months and 1-year prevalence of 
psychiatric disorders (Newman & Bland 1994).  It was found that increased scoring of 
life event over the previous 12 months was correlated with Generalized Anxiety 
Disorder and Major Depressive Episode, with Major Depressive Episodes having 
greater burden of life event than Generalized Anxiety Disorder alone, and mixed Major 
Depressive Episode and Generalized Anxiety Disorder having the greatest burden of 
life events. 
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Simhandl et al. (2015) found that 62.2% of Bipolar Disorders patients had at least one 
life event within 6 months prior to a relapse of mood episode. Risk of depressive relapse 
in Bipolar I Disorder also increase with the number of life events after the index 
episode. 
 
Life events also affect remission of psychiatric illness. Positive life events increase 
remission rates of depression, anxiety and ill-defined emotional distress 2.9-fold. This 
effect is irrespective of the diagnosis and severity of the illness (Neeleman 2003).  
 
2.5 Gap in the Literature and Rationale of the Study  
 
In literature search, there is no Malaysian study examining Anxiety Disorder 
comorbidity in Bipolar Disorders. There is also no local or international study about 
relationship between life events and anxiety in Bipolar Disorders. Because of the high 
comorbidity of Anxiety Disorder and its associated poorer outcome in bipolar patients, 
it is important for clinicians to detect it in clinical settings.   
 
Thus, this study will demonstrate the relationship of clinical and demographic 
parameters, depression and life events with anxiety in Bipolar Disorders.  
 
This study will also look into the detection rate of anxiety by the treating clinicians.  
 
It is important for us to have local data on anxiety in Bipolar Disorders. As anxiety 
symptoms is a poor prognostic factor for Bipolar Disorders, there in a need to know 
detection rate of anxiety in bipolar patients in order to improve the detection and 
treatment of Bipolar Disorders as a whole.  
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CHAPTER 3:  OBJECTIVE AND RESEARCH 
QUESTIONS 
 
 
3.1 General Objective 
 
 
To determine the extent of anxiety symptoms in patients with Bipolar Disorders under 
psychiatric clinic follow-up. 
 
3.2 Specific Objectives  
 
 
1. To examine the presence of anxiety symptoms in Bipolar Disorders outpatients. 
2. To ascertain physician’s detection rate of anxiety symptoms in outpatients with 
Bipolar Disorders. 
3. To study the sociodemographic and clinical factors that are significantly 
associated with anxiety symptoms. 
4. To determine the correlation of anxiety symptoms with manic and depressive 
symptoms and life events.  
 
3.3 Research Questions 
 
 
1. Do anxiety symptoms frequently occur in Bipolar Disorders outpatients?  
2. Do clinicians frequently detect anxiety symptoms in Bipolar Disorders patients in 
clinical setting? 
3. What are sociodemographic and clinical parameters that are associated with anxiety 
symptoms in Bipolar Disorders? 
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4. Do anxiety symptoms correlate with depressive and manic symptoms and life events 
in Bipolar Disorders during follow-up? 
 
3.4 Hypotheses 
 
 
1. Anxiety symptoms frequently occur in Bipolar Disorders outpatients. 
2. Physician detection rate of anxiety symptoms in bipolar patients is low.  
3. Anxiety symptoms are associated with low sociodemographic and poor clinical 
parameters. 
4. Anxiety symptoms are positively correlated with depressive but not manic 
symptoms, and positively correlated with more burden of life events.   
! 14!
 
 
Figure 3.1 Conceptual Frameworks   
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CHAPTER 4:  METHODOLOGY 
 
 
 
 
4.1 Study Setting 
 
 
This study was conducted at the Psychiatric Clinic of Hospital Universiti Sains 
Malaysia (HUSM), Kubang Kerian. It is situated at Kota Bharu, the state capital of 
Kelantan. HUSM is one of the two government tertiary center hospitals in Kelantan. 
 
4.2 Study Design and Study Period 
 
 
This was an observational cross-sectional study conducted between March 2013 and 
December 2014. 
 
4.3 Study Population and Sample ! a) Reference! population:! Reference! population! was! all! Bipolar! Disorders!patients!in!Kelantan.!b) Source! population:! The! source! population! was! all! Bipolar! Disorders!patients!attending!psychiatric!clinic!in!HUSM,!Kota!Bharu!during!the!study!period!that!fulfilled!the!criteria!for!the!study.!c) Study! Population:! Study! populations!were! patients! fulfilling! the! selection!criteria!as!below.!
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4.4 Selection Criteria. 
 
4.4.1 Inclusion criteria. 
 
a) Diagnosed to have Bipolar I or Bipolar II Disorders by the treating clinicians 
b) Age 18 years old and above 
c) At least six months since last admission for mood disorder. This period was 
taken on the basis that a cycle of Bipolar Disorder relapse would usually arrive 
to recovery phase after six months. After this period, the likelihood for the 
patients to relapse reduced (Calabrese et al. 2006; Grunze et al. 2013) and the 
patients would most likely be in a stable clinical condition. 
d) Literate and understands Malay language 
 
4.4.2 Exclusion criteria 
 
 
a) Learning disability or mental retardation 
b) Severe communication problem e.g. deafness and mute 
c) Unable to read and understand Malay 
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4.5 Determination of sample size 
 
a) Prevalence of current Anxiety Disorder in Bipolar Disorders patients in STEP-
BD samples is 30.5% (Simon et al. 2004). 
 
Using single proportion formula: Sample size = (1.96/Δ)2  p(1-p) 
Whereas,   
p = prevalence from previous study  
Δ = between 0.03-0.08 
 
Sample size = 127.24 
 
b) From Simon et al. (2004), drug abuse in bipolar patients with anxiety is 57.93%. 
Using PS software (Dupont & Plummer 2013), for sample size for 2 proportions, 
sample size calculated is 51 for each proportion. 
 
Sample size = 51. 
 
c) From Zutshi et al. (2006), mean age of onset of Bipolar Disorders in subjects 
with Anxiety Disorder is 19.83 (SD 7.9) whereas in subjects without Anxiety 
Disorder, mean age of onset was 23.2 (SD 6.59). 
 
Using PS software, sample size calculated is 76. 
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d) From Mantere et al. (2010), BDI and BAI correlate with correlation coefficient 
of 0.44. Using Stata version 11 software (Gould 2013): 
 
Estimated sample size for Pearson Correlation 
Assumptions: 
Alpha = 0.0500  (two-sided) 
Power = 0.8000 
Null   Rho = 0.0000 
Alt   Rho = 0.4400 
 
Estimated required sample size = 38 
 
Based on the above calculations, sample size of this study,  
N = 127 + 20%  
    =  153 
 
4.6 Sampling method !
Because of limited study duration, samples were chosen by convenience sampling.  
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4.7 Method of data collection 
 
The study was conducted after obtaining approval from Universiti Sains Malaysia 
Ethical Committee. 
 
Patients’ case notes were reviewed for diagnosis of Bipolar Disorders and suitability. 
Suitable patients were approached and explained briefly about the study without 
informing them about depression and anxiety. Patients were able to refuse to participate 
in the study without any reason and they were informed that their quality of treatment 
would be the same even if they refused to participate. 
 
Patients who agreed to participate in the study were met again after seeing the treating 
doctors. They were informed about the study in more detail and were assured of their 
anonymity and the confidentiality of the data obtained. If agreeable, inform consent was 
obtained and questionnaires would be administered. 
 
While interviewing the patients, their behaviors and responses were observed and 
assessed using Young Mania Rating Scale (YMRS) form. 
 
They were asked to fill in Becks Depression Inventory (BDI-Malay) and Beck Anxiety 
Inventory (BAI-Malay). The researcher was available to help the patients to fill in the 
questionnaires.  
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After filling in the questionnaires, they would be asked regarding subjective symptoms 
of mania that were not observed during the interview and their response were rated in 
YMRS.  
 
Finally, the case notes were reviewed again to see whether the treating physician 
detected anxiety symptoms as evidenced by explicit documentation of anxiety such as 
complaints of worry, palpitations, inability to relax and evidence of anxiety during 
mental state examination such as looking tense and fidgety; and prescription of 
antidepressants or benzodiazepine.  
 
All data were collected and analyzed using IBM Statistical Package for the Social 
Sciences (SPSS) version 22 for Macintosh (IBM Corp. 2013). 
 
4.8 Measures Taken to Minimize Study Errors !These!are!steps!taken!to!reduce!errors!during!the!study:!
 
a) Subject was selected using the inclusion and exclusion criteria 
b) The same instruments were used for assessment of the participants 
c) The participants were not being treated by the researcher 
d) The subjects were not informed that this study would assess anxiety symptoms 
prior to them seeing the treating clinicians to avoid bias in reporting symptoms 
e) The subjects are not allowed to bring the questionnaires home to avoid being 
influenced by other people in answering the questions 
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4.9 Research Tools  
 
Four rating scales will be used in this study: 
 
a) Beck Anxiety Inventory (BAI) 
b) Beck Depression Inventory (BDI) 
c) Young Mania Rating Scale (YMRS) 
d) Social Readjustment Rating Scale (SRRS) 
 
4.9.1 Beck Anxiety Inventory (BAI) and Beck Depression Inventory (BDI) 
 
BAI and BDI are self-rated scales to measure anxiety and depression respectively in 
clinical and research settings. Both were created by Aaron T. Beck (Beck et al. 1961; 
Beck et al. 1988).  
 
BAI has 21 items and evaluates key anxiety symptoms, which are psychological and 
somatic symptoms of anxiety such as inability to relax, fear, shortness of breath and 
sweating. Malay version of BAI was validated in local context by Firdaus & Sheereen 
(2011) and showed excellent reliability and validity to be used in Malaysia with 
Cronbach alpha of 0.91 and acceptable concurrent validity (r = 0.22 to 0.67). 
 
BDI also has 21 items and evaluates main symptoms of depression such as mood, 
pessimism and suicidal ideas. BDI-Malay was validated by Mukhtar & Oei (2008) and 
showed good reliability and validity with Cronbach alpha of 0.91 and good concurrent 
validity.  
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The questionnaires were used with the translators’ permission. Cut-off scores for BAI 
and BDI are as follow:  
 
1. Beck Anxiety Inventory (BAI) 
0 – 7  : minimal level of anxiety 
8 – 15  : mild anxiety 
16 – 25 : moderate anxiety 
26 – 63 : severe anxiety 
 
2. Beck Depression Inventory (BDI) 
0 – 9 : minimal depression 
10 – 18 : mild depression 
19 – 29 : moderate depression 
30 – 63 : severe depression!
 
4.9.2 Young Mania Rating Scale (YMRS) 
 
YMRS was developed by Young et al. to measure severity of mania. This scale has 
eleven items and measures objective and subjective symptoms of mania (Young et al. 
1978). The items include, among others, elevated mood, sexual interest and irritability. 
The authors reported interrater reliability of 0.93 with inter-rater coefficient for each 
individuals items ranging from 0.67 to 0.95.  
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No validation study in the context of Malaysia was found. YMRS is widely used in 
local and international researches done in Malaysia (Osman et al. 2009; Chan et al. 
2010; Normala et al. 2010). 
 
The scores of YMRS could be classified as euthymia, and mild to severe 
hypomania/mania or mixed symptoms, as below. 
 
0-4 : euthymia 
5-10 : mild hypomania/mania/mixed symptoms 
11-25 : moderate hypomania/mania/mixed symptoms 
26-60 : severe mania/mixed symptoms 
 
4.9.3 Social Readjustment Rating Scale (SRRS) 
 
As stated earlier, Rahe et al. (1964)  found that life events were associated with disease 
onset. SRRS was created in which the samples were asked to give scoring of life events 
according to the most need for psychosocial adjustment and the least. The result was a 
list of life event and their severity scoring, which they called SRRS (Woon et al. 1971). 
 
Lauer examined 778 English and American sample and found positive relationship 
between SRRS score and generalized state of anxiety (Lauer 1973). Woon et al. (1971) 
compared SRRS between Malaysian and American and they found similarity between 
their attitudes towards life events with remarkable concordance, Spearman’s rho of 0.97 
to 0.91. SRRS is widely used in Malaysia. For example Chan et al. (2010), Zamzam et 
al. (2011) and Fong et al. (2012).  
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4.10 Data Entry !
Data entry and analyses were done using IBM Statistical Package for the Social 
Sciences (SPSS) version 22 for Macintosh (IBM Corp. 2013). Both univariate and 
multivariate analyses were performed. Independent variables that have p-value of < 
0.25 in single linear regression or those judged to be clinically important would be 
entered in multivariate analysis (Bachok 2011). 
 
4.11 Statistical Analysis !
4.11.1 Specific Objective 3:  To study the sociodemographic and clinical factors 
that are significantly associated with anxiety symptoms. 
 
 
1. Statistical analysis: multiple linear regression (MLR) 
2. Dependent variable: severity of anxiety symptoms (BAI score) 
3. Independent variables: Sociodemographic and clinical variables 
Sociodemographic variables:  
1. Age  
2. Sex 
3. Race 
4. Religion 
5. Marital status 
6. Background (rural/urban) 
 
 
7. Education level 
8. Occupation 
9. Income 
10. Living arrangement  
11. Perceived social support 
12. Recent life events 
 
